UHN
[1]
University Health Network（简称UHN，中译名：大学健康网络）是一家有着200多年经营历史的加拿大公司，下辖玛格丽特公主医院、多伦多中心医院和多伦多西部医院等三所大型医院。UHN是加拿大的医疗保健体系的重要里程碑，是加拿大多伦多大学的教学医院。UHN的愿望是实现对全球的影响，它的使命是提供模范的医疗护理，医疗研究和教育。它的宗旨是创建一个充满爱心、有创意和有责任感的教学医院，给病人给社会，给世界带来健康。它的价值观包括：关怀、卓越、团队、创新以及尊重。2008年10月，UHN荣获MediacorpCanada Inc机构颁发的“加拿大最佳雇主100强”称号，同年11月份，UHN又当选由《多伦多星报》授予的“多伦多卓越雇主”。
UHN标志含义三个侧脸形轮廓的图形代表三家医院，也代表了三个承诺，病人护理，医疗研究和医疗教学。它们在一起，形同树叶一样连接，形成一个连贯的圆圈，意味着合作与完成。图形的金色象征着素质，要用成功的态度和卓越的医学不断进行探索，来迎接不断增加的挑战和现实。而文字的蓝色是医院的传统颜色。
多伦多中心医院简称TGH，UHN下三家医院之一。它在心脏监护、器官移植和复杂病人治疗方法上是领先的。 它包含UHN的三个主要中心（彼得芒克心脏中心、移植中心和急救护理中心），它以高素质的志愿者队伍和专门致力于UHN的影响，来实现全球眼光。
多伦多西区医院简称TWH，UHN下三家医院之一。它位于多伦多市中心。TWH已经提供了超过100年的社区照顾及专业服务。它在神经科学、肌肉骨骼健康与关节炎和医疗社区卫生项目提供世界级一流服务。它也有一些门诊诊所。它的核心是以病人为中心的护理。它的神经科学水平世界领先，并且不断冲在研究的前沿，提供最先进的技术治疗。 这家医院还拥有强大的社会关注的焦点，提供信息的创新方案，儿童，老年人，糖尿病患者和许多多元文化群体。
玛格丽特公主医院简称PMH，UHN下三家医院之一。它的研究机构和安大略癌症研究所已实现了在同癌症作斗争的全球领袖的国际声誉。 它的有许多在肿瘤临床研究达到世界领先水平专家，包括：肿瘤外科、骨髓移植、化疗、放射肿瘤学、心理肿瘤学、血液学、放射治疗和医学成像。
关于研究快速的科学发展，使医学研究到了一个令人兴奋的地步。UHN的研究人员也正处于这个兴奋中。在最近一年里，UHN的研究人员在对抗癌症，疟疾，饮食失调，心脏疾病和帕金森氏症等取得重要进展。UHN的研究机构和中心是列入加拿大最优秀行列的：
Ontario CancerInstitute
Director: Dr. Benjamin Neel
Advanced MedicalDiscovery Institute
Director: Dr. Tak Mak
The Campbell FamilyCancer Research Institute
Director: Dr. Benjamin Neel
TheCampbell Family Institute for Breast Cancer Research
Director: Dr. Tak Mak
TorontoGeneral Research Institute
Director: Dr. Richard Weisel
TorontoWestern Research Institute
Director: Dr. Peter St George-Hyslop
为了在生物医学和保健研究领域取得全球影响，在UHN里有大约2700名科学家，技术人员，学生正在共同努力，解决基本问题及其应用研究。 一份“未来计划”指出UHN的战略目标将是优先在以下四个领域进行研究：
* 基因，蛋白质和人类
* 医疗技术创新
* 健康信息
* 再生医学
UHN主要统计数字
* 拥有536名研究人员
* 拥有843名学员
* 拥有1330名技术人员
* 出版1665份出版物
关于教育UHN是加拿大最大的教学医院之一。我们是训练本科声、研究生、住院医生、内科医生、护士和其他卫生保健专业人员的领导者。教导学生健康护理专业不仅是UHN的目标，还要不断提供可持续教育，使UHN能为患者的健康提供相关的和有用的信息。所以，UHN也是一个授权的教育机构。它和多伦多大学医学院建立了伙伴关系，领导着教育与研究工作。UHN是加拿大多伦多大学值得骄傲的分支机构，每年，UHN都对1000多个医学院学生、研究员和护士进行教育，从职业治疗、物理治疗和语音语言病理学等进行培训。UHN和多伦多大学的合作提供了一个用于前沿研究的坚实基础。
关于UHNShanghaiUHNShanghai，全称UHN Shanghai Research & Development Co., Ltd.是UHN下属的全资中国子公司。公司的中文注册名是医恩医疗系统研发（上海）有限公司，简称医恩医疗。公司以加拿大和中国为基地，以先进的化学技术、医学技术为专业主体，集研发、生产、经营于一体，是一支具有专业背景、朝气蓬勃、有高度创造天赋的团队。医恩医疗具有高等级的专业运作资格和良好的商业信誉，被众多化学公司和科研机构认定为“指定供应商”和“国际化学项目合作协调中心”。
UHN世界首创UHN取得的一些成就。
1922: Clinical use of insulin for diabetes – Dr. Frederick Banting and Dr. Charles Best
1935: Clinical use of Heparin as a blood thinner – Dr. Gordon Murray
1946: Design and use of North America’s first artificial kidney – Dr. Gordan Murray
1950: Use of first regulated cardiac pacemaker – Dr. Bill Bigelow
1950s: Use of radiation to cure Hodgkin’s disease – Dr. Vera Peters
1950s: Introduction of lumpectomy for breast cancer – Dr. Vera Peters
1950: Use of total body cooling as a method of making heart surgery safer – Dr. Bill Bigelow
1951: Use of cobalt radiotherapy units for cancer – Dr. Harold Johns
1955: Human heart valve transplant – Dr. Gordan Murray
1960s: Coronary Care Unit – Dr. Robert MacMillan and Dr. Ken Brown
1961: Discovery of blood forming stem cells enabling bone marrow transplants – Dr. Ernest McCulloch and Dr James Till
1965: Developed prototype aneurysm clip – Dr. William Lougheed
1973: Use of pulmonary testing called flow volume loop to diagnose small airway disease (e.g., asthma and COPD) – Dr. Noe Zamel
1975: Development of software used worldwide for 20 years to control radiation therapy – Dr. Jack Cunningham
1976: Identification of P-glycoprotein as a major cause of cancer drug resistance – Dr. Victor Ling
1977: Developed a technique for Peritoneal Dialysis that made it possible on a large scale – Dr. Dimitri Oreopoulos
1978: Discovery of reversibility of brain damage from alcohol with abstinence – Dr. Peter Carlen
1983: Successful single lung transplant – Dr. Joel Cooper
1984: First cloning of the T-cell receptor genes, significant in the field of immunology - Dr. Tak Mak
1985: Reconstruction of the mitral annulus (the supporting structure for cardiac valves) – Dr. Tirone David
1986: Use of a patch technique to repair ruptures of the heart wall following a heart attack – Dr. Tirone David
1986: Successful double lung transplant – Dr. Joel Cooper
1987: Development of a new pig valve to replace the diseased aortic valve – Dr. Tirone David & Dr. Chris Feindel
1988: Operation to spare the aortic valve in patients with aortic aneurysm – Dr. Tirone David and Dr. Chris Feindel
1988: Mapping and surgical correction of cardiac rhythm disorders – Dr. Lynda Mickleborough and Dr. Eugene Downar
1989: Treatment of sleep apnea in patients with heart failure by mechanical assist device (CPAP) reduces morbidity and mortality – Dr. Doug Bradley and Dr. John Floras
1991: Reconstruction of the inflow and outflow tracts of the heart using two conduits – Dr. Tirone David
1992: Developed a novel experimental technique that employs chemical substances to prevent or treat brain damage from stroke or trauma by regulating cell calcium levels – Dr. Chris Wallace
1994: Showing genetic predisposition to developing Reflex Sympathetic Dystrophy – Dr. Angela Mailis
1996: Transplantation of heart cells into damaged and scarred heart muscel to improve heart function – Dr. Ren-Ke Li and Dr. Richard Weisel
1996: Description of a substance that causes intestines to regrow (GLP-2) – Dr. Dan Drucker
1996: Awake craniotomy with same day discharge for brain tumour removal using image guided approach - Dr. Mark Bernstein
1996: Chemotherapy treatment for hormone-resistant prostate cancer – Dr. Ian Tannock and Dr. Malcom Moore
1990s: Identification of genes responsible for hereditary blindness, Alzheimer’s, Lou Gehrig’s and Huntington’s disease – Dr. Peter St. George Hyslop
1999: Identifying the individual brain cells that control pain – Dr. Karen Davis and Dr. Andre Lozano
2000: Identification of novel T regulatory cells to induce tolerance in transplant patients – Dr. Li Zhang
2000: Identification of the novel immune molecule CD 200 to modify host immune response in transplantation – Dr. Reg Gorczynski
2001: Determining the utility of 2 hour post dose cyclosporine levels to improve clinical outcomes in transplantation – Dr. Gary Levy and Dr. Ed Cole
2001: Development of new pig valve and aorta to replace the diseased aortic root – Dr. Tirone David
2001: Discovery that a protein called Interleukin 13 fuels the growth of Hodgkin’s lymphoma – Dr. Tak Mak
2001: Development of the “Marshall Score” for classifying Multiple Organ Dysfunction Syndrome – Dr. John Marshall
2002: Discovery that fragile X syndrome (most common inherited cause of mental retardation) is related to glutamate in the brain – Dr. Peter Carlen
2002: Description of the role of IRAK-4, an immune molecule, critical for first-line defense against infections – Dr. Wen-Chen Yeh, Dr. Tak Mak and Dr. Pam Ohashi
2002: Proof of efficacy of new treatment for HIV infection – Dr. Sharon Walmsley
2002: Demonstrating that dense breast tissue, a major risk factor in breast cancer, is mainly determined by genetic factors - Dr. Norman Boyd.
2002: Identification of protein that triggers autoimmune response in Sj?gren’s syndrome, as well as a vaccine to treat the condition – Dr. Arthur Bookman
2002: Deduction of the structure of a molecular complex in the brain involved in many functions including memory and learning – Dr. Mitsu Ikura
2002: Identifying gene clusters using microarray technology that are involved in lung cancer – Drs. Denis Wigle, Igor Jurisica, Jim Woodgett, Shaf Keshavjee, Gail Darling, Frances Shepherd and Ming Tsao
2003: Developing method for detecting gene mutations that enhance care for families with retinoblastoma – Dr. Brenda Gallie
